《美國股市》「四巫日」道指挫166點 連跌第三週
美國消費數據轉差,帶動美股下跌。加上週五爲「四巫日」(即是即股票期權、股指期貨和股指期權合約同時到期),加劇股市波動。
道瓊斯工業指數跌166.44點或0.48%,收報34,584.88點。全周跌0.1%,是連續第三週下跌。
標準普爾500指數跌40.76點或0.91%,報4,432.99點。全周跌0.6%。
納斯達克指數跌137.95點或0.91%,報15,043.97點。全周跌0.5%。
疫苗股受壓,美國食品藥品管理局(FDA)專家組投票,不建議接種輝端與BioNTech研發的新冠肺炎疫苗加強針,輝端股價跌1%,BioNTech跌逾3%;Moderna跌逾2%。
陶氏化學跌2.89%,是跌幅最大的成份股,開拓重工跌1.89%,蘋果跌1.83%。藥廠安進升0.93%,是升幅最大的道指成份股,聯合醫療升0.8%,美國運通升0.79%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.